Literature DB >> 15043008

Effectiveness of prostaglandin E1 in relieving obstruction in coarctation of the aorta without opening the ductus arteriosus.

L Liberman1, W M Gersony, P A Flynn, J J Lamberti, R S Cooper, T J Stare.   

Abstract

The two main theories regarding the pathogenesis of coarctation of the aorta are the Skodaic hypothesis of ductal tissue constricting the aorta at the level of the insertion of the ductus arteriosus and the flow theory of decreased ascending aortic blood flow in the fetus, which results in associated isthmic narrowing and a localized shelf. To document that ectopic ductal tissue constriction can cause coarctation of the aorta in the absence of a patent ductus arteriosus, we report three cases of infants presenting with critical coarctation who responded to prostaglandin E1 infusion without opening the ductus arteriosus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15043008     DOI: 10.1007/s00246-003-0549-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  9 in total

1.  Efficiency of prostaglandin E1 in a tiny baby with coarctation of the aorta and ligated ductus arteriosus.

Authors:  J M Hascoët; F Didier; P Monin; P Vert
Journal:  Acta Paediatr       Date:  1992-11       Impact factor: 2.299

2.  Patterns of ductal tissue in coarctation of the aorta in the first three months of life.

Authors:  G A Russell; P J Berry; K Watterson; J P Dhasmana; J D Wisheart
Journal:  J Thorac Cardiovasc Surg       Date:  1991-10       Impact factor: 5.209

3.  Echocardiographic evidence for a ductal tissue sling causing discrete coarctation of the aorta in the neonate: case report.

Authors:  P F Callahan; E S Quivers; L M Bradley; J E Sell; G R Martin
Journal:  Pediatr Cardiol       Date:  1998 Mar-Apr       Impact factor: 1.655

4.  Hemodynamic considerations in the development of narrowing of the aorta.

Authors:  A M Rudolph; M A Heymann; U Spitznas
Journal:  Am J Cardiol       Date:  1972-10       Impact factor: 2.778

5.  Coarctation of the aorta explained as a branch-point of the ductus arteriosus.

Authors:  G M Hutchins
Journal:  Am J Pathol       Date:  1971-05       Impact factor: 4.307

6.  Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.

Authors:  M D Freed; M A Heymann; A B Lewis; S L Roehl; R C Kensey
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

7.  Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities.

Authors:  M A Heymann; W Berman; A M Rudolph; V Whitman
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

8.  Coarctation, tubular hypoplasia, and the ductus arteriosus. Histological study of 35 specimens.

Authors:  S Y Ho; R H Anderson
Journal:  Br Heart J       Date:  1979-03

9.  Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.

Authors:  J M Neutze; M B Starling; R B Elliott; B G Barratt-Boyes
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

  9 in total
  4 in total

1.  Efficacy of prostaglandin E1 in relieving obstruction in coarctation of a persistent fifth aortic arch without opening the ductus arteriosus.

Authors:  Sheilia J Carroll; Anne Ferris; Jonathan Chen; Leonardo Liberman
Journal:  Pediatr Cardiol       Date:  2006-11-16       Impact factor: 1.655

Review 2.  Pathology and molecular mechanisms of coarctation of the aorta and its association with the ductus arteriosus.

Authors:  Utako Yokoyama; Yasuhiro Ichikawa; Susumu Minamisawa; Yoshihiro Ishikawa
Journal:  J Physiol Sci       Date:  2016-12-20       Impact factor: 2.781

3.  Endovascular management of coarctation of the aorta.

Authors:  D R Turner; P A Gaines
Journal:  Semin Intervent Radiol       Date:  2007-06       Impact factor: 1.513

4.  Late manifestation of coarctation of the aorta after arterial switch operation for D-transposition of the great arteries with intact ventricular septum.

Authors:  K R Egan; S Srinivasan; S A Hagen; P V Anagnostopoulos
Journal:  Pediatr Cardiol       Date:  2012-05-06       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.